Clinical trialNCT05313165RecruitingInterventional

PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

SponsorLimFlow, Inc.Enrollment100Chronic Limb-Threatening IschemiaCritical Limb IschemiaPeripheral Arterial Disease

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A prospective, single-arm, multi-center study designed to gather additional information on the LimFlow System.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Daniel Clair, MD
Vanderbilt University
Principal Investigator
clinicaltrials.gov ↗
Mehdi Shishehbor
University Hospital Cleveland
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of California, San Diego Health
La Jolla, California, United States
Withdrawn
Stanford University School of Medicine
Palo Alto, California, United States
Completed
Ucsf
San Francisco, California, United States
Completed
Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
Torrance, California, United States
Completed
Yale University
New Haven, Connecticut, United States
Completed
the Cardiac and Vascular Institute
Gainesville, Florida, United States
Arthur Lee, MD
Recruiting
University of Florida
Gainesville, Florida, United States
Completed
Tallahassee Research Institute
Tallahassee, Florida, United States
Withdrawn
Rush University Medical Center
Chicago, Illinois, United States
Completed
Boston Medical Center
Boston, Massachusetts, United States
Withdrawn
Massachusetts General Hospital
Boston, Massachusetts, United States
Anahita Dua, MD
Recruiting
Umass Chan Medical School
Worcester, Massachusetts, United States
Completed
Washington University / Barnes Jewish
St Louis, Missouri, United States
Withdrawn
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
Joceyln Beach, MD
Recruiting
Vascular Institute of Atlantic Medical Imaging
Pomona, New Jersey, United States
Completed
Holy Name Medical Center
Teaneck, New Jersey, United States
Completed
Presbyterian Healthcare
Albuquerque, New Mexico, United States
Completed
Northwell Health Long Island Jewish Medical Center
Lake Success, New York, United States
Yana Etkin
Recruiting
Cornell University
New York, New York, United States
Completed
Mount Sinai
New York, New York, United States
Completed
Nyu Langone Health
New York, New York, United States
Completed
Atrium Health
Charlotte, North Carolina, United States
Completed
University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
Mehdi Shishehbor, MD
Recruiting
Penn State Health
Hershey, Pennsylvania, United States
Completed
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Elizabeth Genovese
Recruiting
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Daniel Clair
Recruiting
Ut Southwestern Medical Center
Dallas, Texas, United States
Completed
Sentara Norfolk General Hospital
Norfolk, Virginia, United States
David Dexter
Recruiting
Ascension Columbia St. Mary'S Hospital
Milwaukee, Wisconsin, United States
Withdrawn
the Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Withdrawn

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 22 Dec 2022
Primary completion: 1 May 2027
Completion: 1 May 2027
Last update posted: 16 Apr 2026
Registered enrollment: 100
Registry id: NCT05313165

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.